BioHealth News Archive
AstraZeneca adds to immuno-oncology leadership team
AstraZeneca (LSE: AZN) and its research arm MedImmune, today announced the appointment of two internationally-recognized immuno-oncology leaders. Dr Jean-Charles Soria joins MedImmune as senior…
Read More
NEA’s Bala Deshpande to set up independent investment firm – Livemint
Bala Deshpande, India head of US venture capital fund NEA, is setting up an independent investment firm along with her three colleagues, said three…
Read More
NIIMBL Quick Start Project call for proposals
NIIMBL is pleased to announce the Quick Start Project (QSP) call. The QSP call solicits proposals for open topic, industry-wide projects focused on the…
Read More
Discovery Communications to acquire Scripps Networks in $14.6 billion deal – Washington Business Journal
After several weeks of talks, Discovery Communications Inc. has reached a deal to acquire the owner of HGTV and Travel Channel. The Silver Spring-based…
Read More
New Alliance Executive Director takes charge
With more than 15 years as a nonprofit professional, Amanda joins the Fort Detrick Alliance with extensive experience in communications, marketing, fundraising, event planning,…
Read More
Local Startup Developing Technology for Real-Time Detection of Bacteria
BHI Q&A with 3i Diagnostics, Inc. President & CEO, Jim Janicki & Chief Technology Officer, Rajesh Krishnamurthy Company: 3i Diagnostics, Inc. “3iDx” www.3iDx.com Location:…
Read More
AstraZeneca’s, MedImmune’s Imfinzi granted breakthrough therapy status
AstraZeneca and MedImmune, have today announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Imfinzi (durvalumab) for the treatment of…
Read More
GlaxoSmithKline to axe 130 brands and overhaul pharma business – AdNews
GlaxoSmithKline (GSK) is axing 130 'non-core' brands and overhauling its prescription drugs business to focus on products that deliver stronger returns. It is also stepping up a cost reduction program…
Read More
AstraZeneca, Merck & Co. in $8.5-Billion Oncology Collaboration – BioPharm International
AstraZeneca and Merck & Co. announced on July 27, 2017 that they have entered a global strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s…
Read More
Inova accelerator seeks personalized-medicine startups Industries | Virginia Business
The Inova Personalized Health Accelerator (IPHA) is preparing to accept applications from early-stage startups focused on predicting, preventing and treating disease. Falls Church-based Inova…
Read More
Encouraging Life Science Innovation: The Value of Accelerator Programs – Technology Networks
The road to launching a life science start-up can be a long and difficult one, with founders often struggling to secure funding and manage…
Read More
Sucampo: A Shift Toward Rare Diseases – Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) – Seeking Alpha
Sucampo’s (NASDAQ:SCMP) share price has been stuck in a range for a considerable time, but the company wasn’t idle - management has been working…
Read More
Innovation Bridge Breakfast Series @ The Rockville Innovation Center
Tuesday, August 22, 2017 from 8:30 AM to 10:30 AM The MITRE Corporation, BHI, and Montgomery County Economic Development Corporation are pleased to announce…
Read More
Don’t run biomedical science as a business – Nature
As the White House and the US Congress continue to lock horns over President Donald Trump's proposed budget, scientists are once again anxious about…
Read More
Flying Dog Brewery, University of Maryland announce partnership focused on hops production – Baltimore Sun
In the craft-beer industry, the majority of hops — the flowers used in production that add bitterness and aroma to the product — come…
Read More